Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kurtis Stemple

Orthopaedic Surgery Barberton, OH Medical Doctor

NPI 1518907179 CMS profile 341525

72 5Th St Se, Suite A, Barberton, OH 44203

Open in the dashboard

General payments

$20,939

149 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kurtis Stemple of Barberton, OH is reported in the CMS Open Payments database as having received $20,939 across 149 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,499 17
2024 General $1,522 25
2023 General $2,049 24
2022 General $2,797 27
2021 General $3,226 19
2020 General $3,069 13
2019 General $5,778 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kurtis Stemple
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kurtis Stemple were reported at $2,499. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Kurtis Stemple Orthopaedic Surgery median Middle half National median
2019 $5,778 $644 $140–$2,844 $163
2020 $3,069 $312 $75–$1,860 $114
2021 $3,226 $520 $117–$2,495 $132
2022 $2,797 $598 $128–$2,731 $149
2023 $2,049 $461 $128–$2,264 $160
2024 $1,522 $497 $134–$2,475 $164
2025 $2,499 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $12,122 91 payments
  2. Rock Medical Orthopedics, Inc. $4,994 26 payments
  3. Stryker Corporation $1,848 20 payments
  4. Exactech, Inc. $984 4 payments
  5. Nexus Medical Technologies LLC $850 4 payments
  6. Zimmer Biomet Holdings, Inc. $67 1 payment
  7. Smith+Nephew, Inc. $27 1 payment
  8. DePuy Synthes Sales Inc. $26 1 payment
  9. Bioventus LLC $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $9,328 7 payments
  2. Travel and Lodging $6,574 25 payments
  3. Food and Beverage $5,037 117 payments
Products named General payments · program years 2019–2025
  1. EQUINOXE $841 3 payments
  2. MAKO Knees, Hips $785 7 payments
  3. MAKO Knees, Hips $417 5 payments
  4. MAKO Joint Replacement Hips, Knees $309 2 payments
  5. TRIATHLON Knees $235 2 payments
  6. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $177 2 payments
  7. OPTETRAK $143 1 payment
  8. TRIATHLON Knees $120 3 payments
  9. Identity $67 1 payment
  10. TORNIER FLEX $40 1 payment
  11. Other $101 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

1,023

Median for Orthopedic Surgery: 203

Drug cost

$9,068

Median for Orthopedic Surgery: $1,433

Branded share of claims

58.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 448 $3,593
Etodolac Generic 56 $2,279
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 148 $1,416
Oxycodone Hcl Generic 77 $456
Prednisone Generic 46 $197
Celecoxib Generic 13 $174
Diclofenac Sodium Generic 14 $159
Tramadol Hcl Generic 68 $154
Nabumetone Generic 14 $134
Methylprednisolone Generic 14 $116

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$78,533

Medicare's payments for the services billed

Medicare patients

186

Average age 73

Services billed

724

125 women, 61 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 38%
Diabetes 32%
Ischemic heart disease 30%
Chronic kidney disease 26%
COPD 24%
Osteoporosis 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

149 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record